147 related articles for article (PubMed ID: 9651460)
1. Early language development in children exposed to or infected with human immunodeficiency virus.
Coplan J; Contello KA; Cunningham CK; Weiner LB; Dye TD; Roberge L; Wojtowycz MA; Kirkwood K
Pediatrics; 1998 Jul; 102(1):e8. PubMed ID: 9651460
[TBL] [Abstract][Full Text] [Related]
2. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.
Boivin MJ; Green SD; Davies AG; Giordani B; Mokili JK; Cutting WA
Health Psychol; 1995 Jan; 14(1):13-21. PubMed ID: 7737068
[TBL] [Abstract][Full Text] [Related]
3. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status.
Le Doaré K; Bland R; Newell ML
Pediatrics; 2012 Nov; 130(5):e1326-44. PubMed ID: 23118140
[TBL] [Abstract][Full Text] [Related]
4. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection.
Drotar D; Olness K; Wiznitzer M; Guay L; Marum L; Svilar G; Hom D; Fagan JF; Ndugwa C; Kiziri-Mayengo R
Pediatrics; 1997 Jul; 100(1):E5. PubMed ID: 9200379
[TBL] [Abstract][Full Text] [Related]
5. The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants.
Whitehead N; Potterton J; Coovadia A
AIDS Care; 2014 Apr; 26(4):497-504. PubMed ID: 24125015
[TBL] [Abstract][Full Text] [Related]
6. Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.
Abrams EJ; Matheson PB; Thomas PA; Thea DM; Krasinski K; Lambert G; Shaffer N; Bamji M; Hutson D; Grimm K
Pediatrics; 1995 Sep; 96(3 Pt 1):451-8. PubMed ID: 7651777
[TBL] [Abstract][Full Text] [Related]
7. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group.
Chase C; Ware J; Hittelman J; Blasini I; Smith R; Llorente A; Anisfeld E; Diaz C; Fowler MG; Moye J; Kaligh LI
Pediatrics; 2000 Aug; 106(2):E25. PubMed ID: 10920181
[TBL] [Abstract][Full Text] [Related]
8. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo.
Van Rie A; Mupuala A; Dow A
Pediatrics; 2008 Jul; 122(1):e123-8. PubMed ID: 18595957
[TBL] [Abstract][Full Text] [Related]
9. High Burden of Morbidity and Mortality but Not Growth Failure in Infants Exposed to but Uninfected with Human Immunodeficiency Virus in Tanzania.
Locks LM; Manji KP; Kupka R; Liu E; Kisenge R; McDonald CM; Aboud S; Wang M; Fawzi WW; Duggan CP
J Pediatr; 2017 Jan; 180():191-199.e2. PubMed ID: 27829511
[TBL] [Abstract][Full Text] [Related]
10. Neurodevelopmental outcomes in young children born to HIV-positive mothers in rural Yunnan, China.
Wu J; Li J; Li Y; Loo KK; Yang H; Wang Q; Duan R; Xiao X; Song X; Yang S; Sun L
Pediatr Int; 2018 Jul; 60(7):618-625. PubMed ID: 29663621
[TBL] [Abstract][Full Text] [Related]
11. Neurodevelopmental outcomes in HIV-infected and uninfected African children.
Debeaudrap P; Bodeau-Livinec F; Pasquier E; Germanaud D; Ndiang ST; Nlend AN; Ndongo FA; Guemkam G; Penda CI; Warszawski J; Koecher D; Faye A; Tejiokem MC;
AIDS; 2018 Nov; 32(18):2749-2757. PubMed ID: 30289800
[TBL] [Abstract][Full Text] [Related]
12. The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with no reported drug use: birth to 24 months.
Gay CL; Armstrong FD; Cohen D; Lai S; Hardy MD; Swales TP; Morrow CJ; Scott GB
Pediatrics; 1995 Dec; 96(6):1078-82. PubMed ID: 7491224
[TBL] [Abstract][Full Text] [Related]
13. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda.
Msellati P; Lepage P; Hitimana DG; Van Goethem C; Van de Perre P; Dabis F
Pediatrics; 1993 Dec; 92(6):843-8. PubMed ID: 8233747
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in outcome and associations with neonatal brain morphology in extremely preterm children.
Skiöld B; Alexandrou G; Padilla N; Blennow M; Vollmer B; Adén U
J Pediatr; 2014 May; 164(5):1012-8. PubMed ID: 24530122
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and motor development in children with vertically transmitted HIV infection.
Blanchette N; Smith ML; Fernandes-Penney A; King S; Read S
Brain Cogn; 2001; 46(1-2):50-3. PubMed ID: 11527362
[TBL] [Abstract][Full Text] [Related]
16. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group.
Spira R; Lepage P; Msellati P; Van De Perre P; Leroy V; Simonon A; Karita E; Dabis F
Pediatrics; 1999 Nov; 104(5):e56. PubMed ID: 10545582
[TBL] [Abstract][Full Text] [Related]
17. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: a prospective study from birth to 2 years. Mothers and Infants Cohort Study.
Belman AL; Muenz LR; Marcus JC; Goedert JJ; Landesman S; Rubinstein A; Goodwin S; Durako S; Willoughby A
Pediatrics; 1996 Dec; 98(6 Pt 1):1109-18. PubMed ID: 8951261
[TBL] [Abstract][Full Text] [Related]
18. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease inhibitor-based highly active antiretroviral therapy.
Lindsey JC; Malee KM; Brouwers P; Hughes MD;
Pediatrics; 2007 Mar; 119(3):e681-93. PubMed ID: 17296781
[TBL] [Abstract][Full Text] [Related]
19. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus infection in HIV-infected versus non-infected infants and HIV disease progression in Cytomegalovirus infected versus non infected infants early treated with cART in the ANRS 12140-Pediacam study in Cameroon.
Kfutwah AK; Ngoupo PA; Sofeu CL; Ndongo FA; Guemkam G; Ndiang ST; Owona F; Penda IC; Tchendjou P; Rouzioux C; Warszawski J; Faye A; Tejiokem MC
BMC Infect Dis; 2017 Mar; 17(1):224. PubMed ID: 28335737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
